I've just been forwarded an email that was originally sent to the National Society of Genetic Counsellors email list on behalf of a reporter with the Washington Post:
Dear NSGC Members,
Washington Post reporter Rob Stein has interviewed NSGC President Liz Kearney on the subject of regulation of genetic testing. Rob would also like to interview patients who have experienced DTC testing. Rob is particularly interested in speaking with patients in the D.C. area who have had a bad experience with DTC testing or who sought the help of a genetic counselor to order the correct test and/or interpret the results. However, he is interested in speaking with any patient who has undergone DTC testing.
If you have patients that would be willing to talk with Rob, please have them contact him directly at the phone number or email below. Rob needs to complete his interviews by Tuesday, July 13.
The Washington Post
(My emphasis in bold.)
...More important is the realization that I am homozygous for the â10â variant of the cytochrome P450 drug metabolizing gene, CYP2P6. As a result, I metabolize Î²-blockers much more slowly than most other Caucasians, .. who largely carry the more efficient metabolizing 1A/1A genotype. Before I had this knowledge, my use of Î²-blockers to control my blood pressure caused me to constantly fall asleep at inappropriate moments. Instead of a daily pill, I now take one every week.
Does anyone have Francis Collins' new book? He gives big props to personal genomics in it.